IntegriChain is the data and application backbone for market access departments of Life Sciences manufacturers. More than 250 manufacturers rely on our ICyte Platform to orchestrate commercial and government payer contracting, patient services, and distribution channels. ICyte unites the financial, operational, and commercial data sets required to support therapy access in the era of specialty and precision medicine, freeing our customers’ best talent to focus on data-driven decisions rather than labor-intensive processes.
We are headquartered in Philadelphia, PA (USA), with offices in Pune, India; and Medellín, Colombia. We offer a hybrid working environment, with periodic visits to office locations for workshops and team collaboration, and occasional international travel based on business need. For more information, visit www.integrichain.com, or follow us on LinkedIn.
The mission of the MDM Analyst is to safeguard the quality of IntegriChain’s master data, including healthcare provider and facility records, by investigating and resolving the issues that obstruct channel visibility for our pharmaceutical manufacturer customers, while continuously improving the processes and tools that keep our data trusted.
IntegriChain is committed to equal treatment and opportunity in all aspects of recruitment, selection, and employment without regard to race, color, religion, national origin, ethnicity, age, sex, marital status, physical or mental disability, gender identity, sexual orientation, veteran or military status, or any other category protected under the law. IntegriChain is an equal opportunity employer; committed to creating a community of inclusion, and an environment free from discrimination, harassment, and retaliation.

IntegriChain is the leading provider of revenue optimization technology and insights for the Pharma industry. The company’s ICyte data-driven commercialization platform enables manufacturers to develop, implement, and operate sustainable growth strategies for life-changing science. Through its unique focus on data, SaaS and BPaaS technology, consulting, and outsourcing, IntegriChain helps manufacturers connect the commercial, financial, and operational dimensions of drug access – all the way from demand through to net revenue optimization. IntegriChain is backed by Nordic Capital, a leading sector-specialized private equity investor with a broad portfolio in Healthcare and Technology. IntegriChain’s umbrella of companies include Blue Fin Group and Federal Compliance Solutions, and the company is headquartered in Philadelphia, PA, with offices in Ambler, PA, and Pune, India.